Gabriel Capellá

Gabriel Capellá is a renowned researcher and current director of the Bellvitge Biomedical Research Institute (IDIBELL). He holds a PhD in Medicine and Surgery from the Autonomous University of Barcelona and has held roles including visiting professor at the University of Michigan and postdoctoral researcher at the California Institute of Biological Research and Sant Pau Hospital. His research focuses on molecular diagnosis of hereditary and sporadic cancers, particularly colorectal cancer.

He served as Scientific Director of IDIBELL (2008–2012) and led the Research and Innovation division at Catalonia’s Health Department (since 2013). Concurrently, he has directed the Hereditary Cancer Program at the Catalan Institute of Oncology (ICO) and led the Hereditary Cancer research group at IDIBELL. His leadership roles include acting director of IDIBELL since July 2023, now fully ratified.

No specific awards or student advisement records are detailed in the provided text. His contributions span clinical research, institutional management, and translational science aimed at advancing cancer diagnosis and treatment strategies.